Ictero Medical, Inc., a Houston, TX-based medical device startup developing a novel cryoablation system to treat high-risk patients with gallstone disease, raised $6M in Series A financing.
The round was led by MedTex Ventures, S3 Ventures, and an undisclosed strategic investor.
The funding will be used to continue product development and complete initial clinical testing.
Led by co-founder and CEO Matthew Nojoomi, Ictero has developed catheter-based technology that can be used in the interventional radiology suite to treat the gallbladder without having to remove it, ultimately allowing clinicians to offer their patients the benefits of surgery without the risk.
The technology leverages existing interventional techniques to deliver cryoablation therapy to effectively defunctionalize the gallbladder without the need to remove it.
To accelerate product development and clinical activities toward regulatory clearance, Ictero Medical recently launched a partnership with Biotex, Inc., a Houston-based medical device development firm. The partnership provides Ictero with comprehensive engineering resources and in-house manufacturing capabilities, as well as capital support from MedTex Ventures through its Biotex Medical Device Fund.
FinSMEs
29/04/2022